ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 95 filers reported holding ATHIRA PHARMA INC in Q4 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $110,126 | -35.0% | 54,518 | -5.1% | 0.00% | – |
| Q2 2023 | $169,383 | -75.9% | 57,418 | -79.5% | 0.00% | – |
| Q1 2023 | $701,598 | -19.4% | 280,639 | +2.2% | 0.00% | – |
| Q4 2022 | $870,647 | +6.2% | 274,652 | -0.6% | 0.00% | – |
| Q3 2022 | $820,000 | -4.1% | 276,293 | -1.3% | 0.00% | – |
| Q2 2022 | $855,000 | -77.1% | 280,044 | +1.3% | 0.00% | -100.0% |
| Q1 2022 | $3,731,000 | -0.8% | 276,372 | -4.3% | 0.00% | 0.0% |
| Q4 2021 | $3,761,000 | +38.7% | 288,687 | -0.1% | 0.00% | – |
| Q3 2021 | $2,711,000 | +162.7% | 289,072 | +186.8% | 0.00% | – |
| Q2 2021 | $1,032,000 | -63.2% | 100,785 | -33.9% | 0.00% | -100.0% |
| Q1 2021 | $2,808,000 | -43.6% | 152,585 | +5.0% | 0.00% | 0.0% |
| Q4 2020 | $4,977,000 | – | 145,307 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,691,623 | $31,126,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 400,000 | $7,360,000 | 2.65% |
| Logos Global Management LP | 1,010,812 | $18,599,000 | 1.82% |
| S Squared Technology, LLC | 181,220 | $3,334,000 | 1.58% |
| Avidity Partners Management LP | 1,677,845 | $30,872,000 | 0.85% |
| Perceptive Advisors | 3,425,916 | $63,037,000 | 0.80% |
| RTW INVESTMENTS, LP | 2,652,553 | $48,807,000 | 0.76% |
| Sofinnova Investments, Inc. | 509,168 | $9,369,000 | 0.56% |
| HighVista Strategies LLC | 32,062 | $590,000 | 0.44% |
| DAFNA Capital Management LLC | 91,531 | $1,684,000 | 0.40% |